Literature DB >> 2934315

In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats.

P Larsson, R Holmdahl, L Dencker, L Klareskog.   

Abstract

The involvement of phenotypically defined cells in the pathogenesis of adjuvant arthritis in rats has been investigated in two different ways. Firstly, immunohistochemical methods have been used to characterize the cellular composition of the arthritic synovial tissue, in particular the pannus tissue close to the destroyed cartilage. It is shown that T-helper lymphocytes dominate the lymphoid infiltrates, and that large numbers of cells expressing Ia are present in the pannus. Secondly, different anti-T cell monoclonal antibodies have been injected into rats in vivo and disease course and phenotypes of synovial cells investigated after different types of treatment. It is shown that the injection of W3/13 (anti-pan T-cell antibodies) delays the development of adjuvant arthritis, whereas a complete elimination of the suppressor/cytotoxic T-cell subset after injection of OX8 antibodies does not affect the disease course.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934315      PMCID: PMC1453748     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS IN RATS WITH LIVING LYMPHOID CELLS OF SENSITIZED DONORS.

Authors:  B H WAKSMAN; C WENNERSTEN
Journal:  Int Arch Allergy Appl Immunol       Date:  1963

2.  Development of arthritis, periarthritis and periostitis in rats given adjuvants.

Authors:  C M PEARSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

3.  Role of T lymphocytes in adjuvant arthritis. II. Different subpopulations of T lymphocytes functioning in the development of the disease.

Authors:  K Kayashima; T Koga; K Onoue
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Identification of a glycophorin-like molecule at the cell surface of rat thymocytes.

Authors:  W R Brown; A N Barclay; C A Sunderland; A F Williams
Journal:  Nature       Date:  1981-02-05       Impact factor: 49.962

5.  In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis.

Authors:  R Holmdahl; T Olsson; T Moran; L Klareskog
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

6.  New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.

Authors:  O Kohashi; K Aihara; A Ozawa; S Kotani; I Azuma
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

7.  The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

8.  Phenotypic characterization of synovial tissue cells in situ in different types of synovitis.

Authors:  S Lindblad; L Klareskog; E Hedfors; U Forsum; C Sundström
Journal:  Arthritis Rheum       Date:  1983-11

9.  Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue.

Authors:  L Klareskog; U Forsum; U K Malmnäs Tjernlund; D Kabelitz; A Wigren
Journal:  Scand J Immunol       Date:  1981-08       Impact factor: 3.487

10.  Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin.

Authors:  H L Currey; M Ziff
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  20 in total

1.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

Review 2.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 3.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Monoclonal antibodies and arthritis.

Authors:  M E Billingham; C Hicks; S Carney
Journal:  Agents Actions       Date:  1990-01

Review 5.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

6.  L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.

Authors:  G Kantwerk; S Cobbold; H Waldmann; H Kolb
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

7.  Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats.

Authors:  K G Stünkel; P Theisen; A Mouzaki; T Diamantstein; H D Schlumberger
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

8.  Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

Authors:  D Moskophidis; S P Cobbold; H Waldmann; F Lehmann-Grube
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

9.  Regulation of resistance against adjuvant arthritis in the Fisher rat.

Authors:  A G van de Langerijt; P L van Lent; A R Hermus; L B van de Putte; W B van den Berg
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

10.  Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat.

Authors:  A G Van de Langerijt; S G Volsen; C A Hicks; P J Craig; M E Billingham; W B Van den Berg
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.